Takeda UK Limited

5 employees

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Investor insights

Sectors invested in

Biotechnology74

Health Care51

Therapeutics38

Pharmaceutical26

Medical23

Life Science15

Biopharma12

Immuno-Oncology7

Medical Device6

Immunotherapy6

Information Technology5

Clinical Trials4

Drug Discovery4

Infectious diseases4

Genetics3

oncology3

Chemical2

Neurology2

Translation Enhancers2

Rare Disease2

Funding rounds participated in

$2.5M sweet spot round size

Most of their 87 investments are in rounds between $15M and $65M

Investor type

Corporate Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Build a Portfolio of Strategic Investments

Therapeutics

Neuroscience

Financial Services

Finance

Collaborative Interactions that result in Synergies with Takeda's considerable R&D Resources.

Gastroenterology

Rare Diseases

Health Diagnostics

Emphasis on Oncology

Date founded

2001

Investments made

Larkspur Biosciences raised $36M on May 23, 2023

Investors: 3E Bioventures Capital, Polaris Partners and Takeda UK Limited

OncoResponse Inc. raised $14M on May 18, 2023

Investors: RiverVest Venture Partners, INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, ARCH Venture Partners, Bering Capital and Takeda UK Limited

Cerevance raised $51M on February 13, 2023

Investors: Dolby Family Ventures, The Dementia Discovery Fund, GV, Foresite Capital, Lightstone Ventures, UPMC Enterprises and Takeda UK Limited

Ensoma raised $85M on January 5, 2023

Investors: Qatar Investment Authority, Mirae Asset MAPS Global Investments Co., Ltd, fred hutch, Viking Global Investors, F-Prime Capital Partners, Catalio Capital Management, -, Solasta Ventures and Takeda UK Limited

hC Bioscience, Inc. raised $16M on November 4, 2022

Investors: ARCH Venture Partners, 8VC and Takeda UK Limited

Enzyre B.V. raised $12M on November 2, 2022

Investors: Advanced Endoscopy, i&i Biotech Fund, Oost NL, Novalis_Fund and Takeda UK Limited

Zelluna Immunotherapy raised undisclosed on August 25, 2022

Investors: Takeda UK Limited

Be Biopharma raised $130M on April 14, 2022

Investors: Alta Partners, Bristol-Myers Squibb, UK, ARCH Venture Partners, Longwood Fund, Atlas Venture, RA Capital Management, L.P. and Takeda UK Limited

hC Bioscience, Inc. raised $24M on February 23, 2022

Investors: ARCH Venture Partners, 8VC and Takeda UK Limited

Koneksa raised $45M on February 7, 2022

Investors: Waterline Ventures, dRx data, Spring Mountain Capital and Takeda UK Limited